Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
ImmunoCellular Announces Receipt of Notice of Noncompliance with The NYSE American Continued Listing Standards PR Newswire LOS ANGELES, Oct. 17, 2018 LOS ANGELES, Oct. 17, 2018 /PRNewswire/...
ImmunoCellular Therapeutics Announces Delisting and Deregistration of Common Stock and Listed Common Stock Warrants Management Team to Transition to Consulting Roles in Effort to Streamline...
ImmunoCellular Therapeutics Provides Corporate Update and Reports Second Quarter 2018 Financial Results -Ongoing Exploration of Strategic Opportunities- -Continued Progress in Stem-to-T-Cell...
ImmunoCellular Therapeutics Announces Agreement on Terms of Settlement of Federal Class Action Shareholder Lawsuit Settlement Will Be Paid By Company's Insurance Carrier PR Newswire LOS ANGELES...
ImmunoCellular Therapeutics Announces First Quarter 2018 Financial Results -Continued Progress in Stem-to-T-Cell Program- -Ongoing Exploration of Strategic Opportunities- PR Newswire LOS ANGELES...
ImmunoCellular Therapeutics Announces Achievement of Next Key Milestone in Stem-to-T-Cell Research Immuno-Oncology Program PR Newswire LOS ANGELES, April 12, 2018 LOS ANGELES, April 12, 2018...
ImmunoCellular Therapeutics Receives Audit Opinion with Going Concern Explanation PR Newswire LOS ANGELES, March 26, 2018 LOS ANGELES, March 26, 2018 /PRNewswire/ -- ImmunoCellular Therapeutics...
ImmunoCellular Therapeutics Announces Fourth Quarter and Full Year 2017 Financial Results -Continued Progress in Stem-to-T-Cell Program- -Strengthened Financial Condition- -Conference Call Today...
ImmunoCellular Therapeutics to Report Fourth Quarter and Full Year 2017 Financial Results on March 13, 2018 PR Newswire LOS ANGELES, March 7, 2018 LOS ANGELES, March 7, 2018 /PRNewswire/...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.0555 | -27.0731707317 | 0.205 | 0.205 | 0.105 | 910 | 0.17092863 | CS |
| 4 | 0.0705 | 89.2405063291 | 0.079 | 0.205 | 0.079 | 2047 | 0.16293459 | CS |
| 12 | -0.0195 | -11.5384615385 | 0.169 | 0.205 | 0.079 | 1802 | 0.12391962 | CS |
| 26 | -0.0495 | -24.8743718593 | 0.199 | 0.205 | 0.072 | 2371 | 0.1430389 | CS |
| 52 | -0.1405 | -48.4482758621 | 0.29 | 0.3999 | 0.0182 | 2867 | 0.19138816 | CS |
| 156 | -0.3505 | -70.1 | 0.5 | 0.94 | 0.0182 | 5312 | 0.37483555 | CS |
| 260 | 0.1105 | 283.333333333 | 0.039 | 0.98 | 0.0161 | 19744 | 0.17401485 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
